Genomic heterogeneity of type II CD36 deficiency

Clinica Chimica Acta

Volumn 321, Issue 1-2, 2002, Pages 97-106

  Imai, Makoto ^a   Tanaka, Takao ^a   Kintaka, Taigo ^a   Ikemoto, Toshiyuki ^a   Shimizu, Akira ^a   Kitaura, Yasushi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

CD36 deficiency; Flow cytometry; Genotype; Phenotype

Indexed keywords

CD36 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ANALYTIC METHOD; ARTICLE; CD36 DEFICIENCY TYPE 2; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GENE DOSAGE; GENE FREQUENCY; GENETIC CODE; GENETIC HETEROGENEITY; GENOTYPE; HEREDITY; HUMAN; JAPAN; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; THROMBOCYTE; WILD TYPE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIGENS, CD36; BASE SEQUENCE; BLOOD PLATELETS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GENE DELETION; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; MONOCYTES; MUTATION; PEDIGREE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REPRODUCIBILITY OF RESULTS;

EID: 0036267151     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00102-X     Document Type: Article

References (27)

1. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction and transfusion medicine
2. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm
3. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion
4. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
5. Hypertrophic cardiomyopathy with type I CD36 deficiency
6. Scintigraphic evidence for a specific long-chain fatty acid transporting system deficit and the genetic background in a patient with hypertrophic cardiomyopathy
7. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations
8. Identification of molecular defect in a subject with type I CD36 deficiency
9. Family studies of type II CD36 deficient subjects: Linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency
10. 478C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency
11. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency
12. Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV
13. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
14. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
15. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy
16. CD36 deficiency associated with insulin resistance
17. Metabolic changes in human CD36 deficiency displayed by glucose loading
18. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension
19. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats
20. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia and myocardial hypertrophy
21. CD36 expression is altered in retinal pigment epithelial cells of the RCS rat
22. Identification of CD36 as the first gene dependent on the β-cell differentiation factor Oct-2
23. CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency
24. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients
25. A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation
26. Fatty acid transport proteins facilitate fatty acid uptake in skeletal muscle
27. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy